EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Association between plasma p‐tau181 levels and the evolution of cognitive and physical performance in a cohort of cognitively impaired older adults with frailty criteria: Longitudinal data from the CogFrail study

Davide Angioni iD, Julien Delrieu, Christelle Cantet, Gaelle Soriano, Federico Bellelli, Bruno Vellas, Sandrine Andrieu, Sandrine Sourdet

Alzheimer's & Dementia: Translational Research & Clinical Interventions · 2026-01 · 12 (1)

DOI: 10.1002/trc2.70213 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia: Translational Research & Clinical Interventions, online erschienen am 20.03.2026. Verfasst von Davide Angioni und 7 weiteren Autor:innen. Beteiligte Einrichtung: IHU HealthAge, Cité de la santé, place Lange Toulouse France. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: MSDAVENIR.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION Evidence linking plasma phosphorylated tau (p‐tau)181 to cognitive decline comes from studies conducted in younger, selected research populations, raising questions about the generalizability of these findings to older adults meeting frailty criteria. The association between plasma p‐tau181 and physical parameters has been sparsely investigated. This study aims to assess the relationship between plasma p‐tau181 levels and the trajectories of cognitive and physical performance in a population of pre‐frail and frail older adults. METHODS This is a 2‐year analysis based on longitudinal data from the CogFrail study. Plasma p‐tau181 was measured using the SIMOA method. High p‐tau181 levels were defined by a cut‐off corresponding to the highest tertile of its distribution. Longitudinal changes from baseline in functional/cognitive (Mini‐Mental State Examination [MMSE], Clinical Dementia Rating Sum of Boxes [CDR‐SoB], Activities of Daily Living [ADL]‐Index) and physical outcomes (gait speed, handgrip strength, Short Physical Performance Battery, and chair rise time) according to plasma p‐tau181 status (high vs. low/intermediate levels) were compared using linear mixed‐effects models. RESULTS Among the 227 patients with available plasma p‐tau181 concentrations (mean age: 82.1 ± 5.1 years, 63.4% women), 77 (33.9%) were classified as having high plasma p‐tau181 levels. Mean plasma p‐tau181 values were 14.64 (± 3.83) and 29.96 (± 7.63) pg/mL in the low/intermediate and high level groups, respectively. Over 2 years, participants with high p‐tau181 levels showed greater progression in CDR‐SoB ( β = +0.43; 95% confidence interval [CI]: +0.24 to +0.63, log transformed), greater decline in MMSE ( β = −2.09; 95% CI: −3.17 to −1.02), ADL ( β = −0.31; 95% CI: −0.54 to −0.08), and handgrip strength ( β = −2.66; 95% CI: −4.10 to −1.23), compared to those with low/intermediate levels. DISCUSSION In a population of pre‐frail and frail older adults with cognitive impairment, individuals with elevated plasma p‐tau181 levels showed greater cognitive and physical deterioration over a 2‐year period. Age‐related loss of proteostasis, responsible for amyloidopathy and associated tauopathy, may play a role not only in cognitive but also in physical decline, representing a potential target for preventive and therapeutic interventions.

Schlagwörter

Stichwörter der Autor:innen

Alzheimer's diseaseblood‐based biomarkerscognitive frailtydual decline

Autor:innen und Institutionen

  • IHU HealthAge, Cité de la santé, place Lange Toulouse France.
  • Aging Research Team Centre for Epidemiology and Research inPopulation Health (CERPOP) INSERM-University of Toulouse Toulouse France.

ORCID-Profile: Davide Angioni

Förderung

  • MSDAVENIR

Zitieren

APA

Angioni, D., Delrieu, J., Cantet, C., Soriano, G., Bellelli, F., Vellas, B., Andrieu, S., & Sourdet, S. (2026). Association between plasma p‐tau181 levels and the evolution of cognitive and physical performance in a cohort of cognitively impaired older adults with frailty criteria: Longitudinal data from the CogFrail study. Alzheimer's & Dementia: Translational Research & Clinical Interventions, 12(1). https://doi.org/10.1002/trc2.70213

Vancouver

Angioni D, Delrieu J, Cantet C, Soriano G, Bellelli F, Vellas B, et al. Association between plasma p‐tau181 levels and the evolution of cognitive and physical performance in a cohort of cognitively impaired older adults with frailty criteria: Longitudinal data from the CogFrail study. Alzheimer's & Dementia: Translational Research & Clinical Interventions. 2026;12(1). doi:10.1002/trc2.70213

BibTeX
@article{Angioni2026,
  author = {Angioni, Davide and Delrieu, Julien and Cantet, Christelle and Soriano, Gaelle and Bellelli, Federico and Vellas, Bruno and Andrieu, Sandrine and Sourdet, Sandrine},
  title = {Association between plasma p‐tau181 levels and the evolution of cognitive and physical performance in a cohort of cognitively impaired older adults with frailty criteria: Longitudinal data from the CogFrail study},
  journal = {Alzheimer's & Dementia: Translational Research & Clinical Interventions},
  year = {2026},
  volume = {12},
  number = {1},
  doi = {10.1002/trc2.70213}
}
Kostenlos starten →